Following the outcome of successful medical trials in China for the treatment of 100 people with COVID-19 by the administration of the drug Hydroxychloroquine, the UK Government on 13 March 2020 banned the export of Hydroxychloroquine, reserving its supplies for its citizens.

On 18 March 2020, it was announced in Brisbane that Clive Palmer had donated $1,000,000 to the RBWH Foundation Coronavirus Action Fund.

University of Queensland Centre for Clinical Research director Professor David Paterson, who is also an infectious disease physician at the Royal Brisbane and Women’s Hospital, stated that he had seen two drugs used to treat other conditions able to wipe out the virus in test tubes.

He said one of the medications, given to some of the first people to test positive for COVID-19 in Australia, had already resulted in “disappearance of the virus” and complete recovery from the infection.

“What we want to do at the moment is a large clinical trial across Australia, looking at 50 hospitals, and what we’re going to compare is one drug, versus another drug, versus the combination of the two drugs,” Prof Paterson said. “Hydroxychloroquine is one of those drugs.”

Mr Palmer confirmed that the Hydroxychloroquine results in treating patients was the main reason he donated $1,000,000 to the trial. Mr Palmer said he was confident the drug would be valuable in saving Australian lives.

Prof Paterson said it wasn’t a stretch to label the drugs “a treatment or a cure”.

On 20 March 2020, the results of a French medical trial using Hydroxychloroquine for the treatment of COVID- 19 was released and hailed as a success worldwide.

The French Government was offered millions of courses of Hydroxychloroquine by the French pharmaceutical company Sanofi to treat its citizens. Hydroxychloroquine is used in China and France for the treatment of COVID- 19.

On 21 March 2020, President Trump of the United States of America approved the use of Hydroxychloroquine for US patients.

On 23 March 2020, it was reported that Jordan’s Food and Drug Administration (FDA) had authorised physicians to use Hydroxychloroquine along with an antiviral medicine as a treatment for COVID-19 in patients in an advanced stage of the disease.

On March 24, 2020, US President Donald Trump states he has fast-tracked approval of Hydroxychloroquine and will begin its distribution in New York. President Trump said the US Government would make 50 million doses available to its citizens free of charge.

Clive Palmer agrees to fund the
manufacture or acquisition of over
1,000,000 courses of Hydroxychloroquine for Australians

Clive Palmer has appointed Brisbane pharmacist Jeremy Sheridan to lead the effort to oversee the large scale manufacturing of Hydroxychloroquine in Australia and the acquisition of the drug as soon as possible.

Mr Sheridan stated in Brisbane today “While the clinical trials in Australia in 50 hospitals may take four to five months to complete it is important that arrangements for the large-scale manufacture or acquisition of Hydroxychloroquine proceed quickly so that there will be no delay making a successful treatment available to all Australians as soon as possible.

“We cannot wait. To delay now could cost Australian lives in the coming months. We cannot wait to start the process of large-scale acquisition of the drug.

“When the drug is required it needs to be available,’’

Mr Sheridan said.

Clive Palmer confirmed last Friday he had discussions with Health Minster Greg Hunt and other ministers and members of the Australian Government, as well as senior officials of the Health Department, to cut through any red tape that would delay an immediate response to ensure that all Australians would have access to the drug as soon as possible.

Mr Palmer stated that he had agreed to personally fund the acquisition or manufacture of over 1,000,000 courses of Hydroxychloroquine and to make it available to the government to be placed on the National Health Stockpile for the free use of Australians affected by COVID-19.

Mr Palmer confirmed that would result in over 30,000,000 doses being placed in the National Health Stockpile.

“The first 1,000,000 courses will be the first step to ensure that all Australians regardless of their financial circumstances will have access to Hydroxychloroquine as soon as possible,’’ Mr Palmer said.

“We are proceeding as fast as we can to initiate the manufacturing process in Australia, I have a strong commitment not to let the community down. I will spend whatever it takes and do the best that I can to

ensure that when the time comes, we as Australians can respond to the challenge that faces us all.

“At this time of national crisis in our country, all Australians must do whatever they can to help their fellow Australians,’’ Mr Palmer said.

“There are many other Australians beside me that can provide financial support necessary to allow our medical resources to be deployed in the shortest possible time to save lives.

“I want all Australians who have done well in this country to remember their fellow Australians and the sacrifices that have been made by previous generations and dig deep to support all efforts necessary to defeat this threat to our lives,’’ he said.

The director of the Gold Coast medical centre Dr Reza Madah has been appointed as medical advisor to assist the effort.

Dr Reza Madah said “We need more Australians like Clive Palmer who understand the urgency and the challenges facing the nation and for Australians to come forward and to commit whatever they can in the fight against COVID-19 and supporting the medical and research community.

“The urgency of the situation cannot be left to Government alone, we need quick decisions and the timely commitment of funds and resources.”

Mr Palmer thanked Minister Hunt and the Australian Government for their support and all they had done and would do to make Australia independent to facilitate the acquisition and manufacture of drugs necessary to treat COVID-19 in the shortest possible time.

“The Commonwealth Health Department was assisting in ensuring that Australia’s high standards are maintained in the process,’’ Mr Palmer said.

When asked if he was concerned about the millions of dollars he was committing to fight COVID-19 may not achieve all that he hoped, Mr Palmer said “If we are wrong, I lose some money but if we are right we may save the lives of thousands of our citizens. Australia must move now with urgency.”

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

A Conversation With Dr. Brian Tyson – The Chloroquine Wars Part XLI

The data from the vaccine trials must be recalculated under the lens that some of the serious adverse events (SAEs) should be treated as COVID-19 cases.
There may not be any vaccine efficacy in the data at all if some of the post-vaccination deaths are due to vaccine-induced COVID-19. It could even be the case that the mortality efficacy goes negative. My implied lives saved calculations put this easily in the realm of possibility. The only way to know is for authorities to organize and compile the data. And while a risk analysis is certainly due after more than six months of hundreds of millions of doses delivered, there is little indication authorities have bothered with the process. That’s more than a bit unsettling.

Read More »

Dr. Brian Tyson, USA: Hydroxychloroquine – Data, Strategies and Success Treating over 6000 Covid Patients

We continue to delve extensively into the COVID-19 data with esteemed statistician, Mathew Crawford. In this episode, we take a closer look at the use of early treatment and its success. Mathew has been researching the data from Dr. Brian Tyson, who has successfully treated over 6000 patients who contracted COVID throughout the pandemic. It is my great honor to have Dr. Tyson here on this episode to not only discuss the data, but also the strategies that he has been using throughout the pandemic.

Read More »